Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program
In these ambulatory cancer patients, the interest in tailored monitoring of DRPs as a whole, including the prevention and management of drug interactions in addition to symptoms and adverse effects, is highlighted.
Authors
- Florence Ranchon (ORCID: https://orcid.org/0000-0002-9181-4231)
- Gilles Freyer
- Magali Maire
- Claire Lattard
- Gabriel Antherieu (ORCID: https://orcid.org/0000-0002-6043-2580)
- Catherine Rioufol (ORCID: https://orcid.org/0000-0002-9728-8092)
- Thibaut Reverdy
- Chloé Herledan (ORCID: https://orcid.org/0000-0002-3170-4751)
- Benoît You (ORCID: https://orcid.org/0000-0002-3177-8857)
- Hervé Ghesquières (ORCID: https://orcid.org/0000-0002-3131-3718)
- Marine Rivat
- Anne-Gaëlle Caffin
- Marie‐Anne Cerfon
- S. M. France
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Lyon College (US)
- Hospices Civils de Lyon (FR)
- Hôpital Lyon Sud (FR)
Publication Details
- Journal
- The Oncologist
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1093/oncolo/oyae241
- Citations
- 3
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.85